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Background
Spleen Tyrosine Kinase (SYK) is a key activator of signal-
ing pathways downstream of multiple surface receptors
implicated in asthma. SYK function has been extensively
studied in Last cells downstream of the high-affinity IgE
receptor (FcεR1). Most studies evaluating SYK function in
preclinical models have relied on poorly selective com-
pounds, anti-sense oligonucleotides, or SYK knockout
mice. Here we describe the characterization of SYK
mechanism in multiple in vivo model settings.
Materials and methods
The effect of SYK inhibitor MRK-A on allergic airway
responses was evaluated in IgE-mediated tracheal extrava-
sation in rat, Brown Norway Ova rat models of allergic
inflammation and the sheep inhaled ascaris allergen chal-
lenge model.
Results
MRK-A dose-dependently blocked IgE-mediated tracheal
extravasation in rat. In a Brown Norway rat ovalbumin-
sensitized airway challenge model oral dosing of MRK-A
led to a dose-dependent inhibition of airway inflammation.
Intravenous dosing of MRK-A was able to significantly
inhibit both early and late allergen- induced changes in
airway resistance in an ascaris-sensitive sheep allergen
challenge model as well as airway hyper responsiveness.
Conclusions
Here we demonstrated that SYK mechanism plays a sig-
nificant role in several in vivo allergen challenge models.
This ranges from simple PK/PD mast cells driven models
such as the IgE-mediated tracheal extravasation to the
more complex and clinically relevant sheep inhaled aller-
gen challenge model.
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